
    
      In addition to the key secondary outcome parameters several potential biomarkers were
      evaluated as exploratory parameters.

      Issues on safety are addressed in the Adverse Event section.

      The following acronyms and abbreviations were used in the Adverse Event section and
      Limitations and Caveats section:

        -  gastrointestinal (GI)

        -  not otherwise specified (NOS)

        -  central nervous system (CNS)

        -  National Cancer Institute Common Terminology Criteria (NCI-CTC)

        -  Medical Dictionary for Regulatory Activities (MedDRA)

        -  System Organ Class (SOC)

        -  interim analysis (IA)
    
  